2013
DOI: 10.1007/s10822-013-9667-1
|View full text |Cite
|
Sign up to set email alerts
|

Pyridones as NNRTIs against HIV-1 mutants: 3D-QSAR and protein informatics

Abstract: CoMFA and CoMSIA based 3D-QSAR of HIV-1 RT wild and mutant (K103, Y181C, and Y188L) inhibitory activities of 4-benzyl/benzoyl pyridin-2-ones followed by protein informatics of corresponding non-nucleoside inhibitors' binding pockets from pdbs 2BAN, 3MED, 1JKH, and 2YNF were analysed to discover consensus features of the compounds for broad-spectrum activity. The CoMFA/CoMSIA models indicated that compounds with groups which lend steric-cum-electropositive fields in the vicinity of C5, hydrophobic field in the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 45 publications
0
16
0
Order By: Relevance
“…A series of models were constructed with an increasing number of partial least squares (PLS) analysis factors. The numbers of components in the PLS models were optimized by using the cross-validated correlation coefficient (Q 2 ), non-cross-validated correlation coefficient (R 2 ), standard error estimate (SEE) and F-statistic values (F ) , etc ., which were obtained from the leave-one-out (LOO) cross-validation procedures [37,38]. According these parameters, the best model was chosen to predict bioactivities of compounds.…”
Section: Methodsmentioning
confidence: 99%
“…A series of models were constructed with an increasing number of partial least squares (PLS) analysis factors. The numbers of components in the PLS models were optimized by using the cross-validated correlation coefficient (Q 2 ), non-cross-validated correlation coefficient (R 2 ), standard error estimate (SEE) and F-statistic values (F ) , etc ., which were obtained from the leave-one-out (LOO) cross-validation procedures [37,38]. According these parameters, the best model was chosen to predict bioactivities of compounds.…”
Section: Methodsmentioning
confidence: 99%
“…According to the SAR and structure-based drug-design strategies, the substituents on C3, C4, and C6 of the 2-pyridone ring are important for the anti-HIV-1 activity. [32] By using these results and isostericp rinciple, pyridinone derivatives 54 and 55 were prepared, whichs howed sub-micromolar IC 50 values against HIV-1 RT (Figure 26). [22a] Rationalh ybridization and crystallographic overlay of two structurally distinct lead compounds TMC125 and R221239 led to compound 56 as ap otent anti-HIV-1 agent with an EC 50 value of 0.15 mm ( Figure 27).…”
Section: Diarylpyri(mi)dines Diarylanilines and Diarylpyridinonesmentioning
confidence: 99%
“…(vi) PLS analysis. The CoMFA and CoMSIA 3D-QSAR models were derived using the PLS regression procedure of SYBYL (39). The predictive ability of the model was measured in terms of leave-one-out predicted cross-validated r 2 (r cv 2 or Q 2 ), as shown in equation 2.…”
Section: Synthesis Of Compoundsmentioning
confidence: 99%
“…The number of components leading to the lowest standard error of prediction (SEP) was used as the optimum number of components (ONC) to generate the final PLS regression models. The models were validated through the bootstrapping analysis for 100 runs and the cross-validation analysis (leave-half-out and leave 20% out; 50 runs each) (39). The CoMFA and CoMSIA equations were plotted as contour maps to express the percent contribution of the respective fields to the activity.…”
Section: Synthesis Of Compoundsmentioning
confidence: 99%